Pfizer Inc.
Pfizer Inc. (PFE) Revenue
Annual & quarterly revenue history · segment & region breakdown
PFE · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsPfizer Inc. trailing twelve-month (TTM) revenue is $63.31B, a decrease of 1.65% year-over-year from $62.58B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $62.58B | -$1.05B | -1.65% |
| 2024-12-31 | $63.63B | +$4.07B | +6.84% |
| 2023-12-31 | $59.55B | -$40.78B | -40.64% |
| 2022-12-31 | $100B | +$19.04B | +23.43% |
| 2021-12-31 | $81.29B | +$39.64B | +95.16% |
| 2020-12-31 | $41.65B | +$0.48B | +1.16% |
| 2019-12-31 | $41.17B | -$12.47B | -23.25% |
| 2018-12-31 | $53.65B | +$1.10B | +2.10% |
| 2017-12-31 | $52.55B | -$0.28B | -0.53% |
| 2016-12-31 | $52.82B | +$3.97B | +8.13% |
Compare revenue vs peers
Drug Manufacturers - GeneralCompare PFE revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Pfizer Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Pfizer Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Pfizer Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PFE revenue · 4 questionsPFE's trailing twelve-month (TTM) revenue is $63.31B. That is a decrease of 1.65% year-over-year from $62.58B in FY2025.
▸ Source: FMP · Pfizer Inc. SEC filings · GAAP · Pfizer Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026